With gene editing — and pigs — CALS scientists are developing a model for “precision medicine,” the possibility of highly individualized treatments for patients living with the rare disease called NF1

Travis Balinas BS’09 MS’10 Life Sciences Communication Balinas works as an inbound marketing manager for Zenoss, a start-up company that makes commercial open source software […]